VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Vaprisol In 5% Dextrose In Plastic Container patents expire, and when can generic versions of Vaprisol In 5% Dextrose In Plastic Container launch?
Vaprisol In 5% Dextrose In Plastic Container is a drug marketed by Cumberland Pharms and is included in one NDA.
The generic ingredient in VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER is conivaptan hydrochloride. Additional details are available on the conivaptan hydrochloride profile page.
Summary for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 16 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jesse Corry | Phase 1 |
| University of Florida | Phase 2 |
| Finn Gustafsson | Phase 4 |
See all VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
US Patents and Regulatory Information for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharms | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-002 | Oct 8, 2008 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Cumberland Pharms | VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER | conivaptan hydrochloride | INJECTABLE;INTRAVENOUS | 021697-002 | Oct 8, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER
See the table below for patents covering VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Taiwan | 279163 | ⤷ Try a Trial | |
| Ukraine | 64690 | A CONDENSED BENZADEPINE DERIVATIVE, AN INTERMEDIATE COMPOUND FOR PREPARING THEREOF AND A PHARMACEUTICAL COMPOSITION | ⤷ Try a Trial |
| Poland | 177738 | ⤷ Try a Trial | |
| Australia | 7195794 | ⤷ Try a Trial | |
| Spain | 2228405 | ⤷ Try a Trial | |
| Finland | 113178 | ⤷ Try a Trial | |
| European Patent Office | 1097920 | Intermédiaires pour la production de dérivés benzazépine condensés (Intermediate for condensed benzazepine derivatives) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
